When a listing appears for a community pharmacy, the instinct is to look at the shop, the location and the headline turnover. Those are the wrong starting points. The asset you are acquiring is the NHS pharmaceutical contract that entitles the pharmacy to dispense NHS prescriptions and receive reimbursement under the Drug Tariff. Without that contract, the premises are a retail unit. This checklist works through the regulated, financial and structural steps a buyer needs to navigate, in the order they matter.
This guide covers England. Scotland, Wales and Northern Ireland operate under different contractual frameworks; NHS contract content here reflects the England Community Pharmacy Contractual Framework (CPCF).
The short answer: the NHS contract is the asset and market entry is regulated
A community pharmacy's income is reimbursement plus remuneration under the Community Pharmacy Contractual Framework, not shop takings. The value follows the contract. Under the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, opening, relocating or buying a pharmacy requires satisfying a regulated market-entry process. A change of ownership does not automatically preserve or transfer the contract: the incoming owner must comply with the Regulations and meet registration requirements before dispensing can continue under the new ownership.
This single fact separates pharmacy acquisition from buying most other businesses, and it is the point most general business brokers understate.
What you are actually buying: the contract, item volume and goodwill
The three components that drive the value of a community pharmacy are:
- The NHS contract. The right to dispense NHS prescriptions and receive NHSBSA reimbursement, governed by the 2013 Regulations. Without it, the business is a retail shop with a dispensary fit-out.
- Item volume. The number of prescription items dispensed per month is the primary driver of dispensing income and, in turn, of goodwill value. A buyer paying a premium is paying for a contracted, recurring income stream measured in items per month.
- Goodwill. In a pharmacy, goodwill sits on top of the tangible assets and is almost entirely attributable to the contract and item volume. What pharmacy goodwill is worth is explored in detail in a sibling post; this checklist covers the tax treatment at acquisition and its due-diligence implications.
Shop fittings, dispensary robots, refrigeration and signage are tangible fixed assets. They are a small fraction of the total consideration in most pharmacy transactions. Overweighting them in valuation is a first-time-buyer error.
Regulated market entry: the NHS (Pharmaceutical and LPS) Regulations 2013
The NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 set the framework for market entry in England. The key principle is that the pharmaceutical needs of a neighbourhood are assessed by NHS England and pharmacy provision is controlled accordingly. This means:
- A new pharmacy cannot simply open anywhere; it must either fit a market-entry category (for example, a 100-hours pharmacy or a distance-selling pharmacy) or be an existing contracted pharmacy changing hands.
- A change of ownership of an existing pharmacy requires the incoming owner to notify the NHS and satisfy the Regulations' conditions. The outgoing owner's contract does not automatically vest in the buyer on completion.
- Relocating a pharmacy after purchase also engages a separate process under the Regulations and is not guaranteed to be approved.
Legal and regulatory advice on the change-of-ownership notification process sits with a specialist healthcare solicitor. From the accounting side, the key implication is that the transaction timetable must allow for the notification and approval process, and no income from the NHS should be assumed until the ownership change is formally registered. The FP34 payment cycle (monthly submission, payment roughly two months later under the NHSBSA payment process) means a delayed approval has a working-capital cost that must be modelled.
GPhC registration and the superintendent pharmacist requirement
Every pharmacy premises must be registered with the General Pharmaceutical Council (GPhC). When ownership changes, the registration must reflect the new owner. For companies (as opposed to individual pharmacist-owners), there is an additional requirement: the company must appoint a GPhC-registered superintendent pharmacist.
The superintendent pharmacist takes named responsibility for the pharmacy's pharmaceutical services. This is an ownership and registration mechanics requirement; this post does not cover the professional or clinical dimensions of the role, which sit with the GPhC and the Royal Pharmaceutical Society.
Practical implications for a buyer:
- If buying through a company, the superintendent pharmacist must be identified and confirmed before or at completion, not after.
- If the selling pharmacist-owner was also the superintendent and they are leaving the business, a gap in superintendent cover is a regulatory problem, not just an operational one.
- GPhC registration of the premises under the new ownership is part of the completion checklist, not a post-completion tidying exercise.
The first structuring decision: share purchase versus asset purchase
Before due diligence deepens and certainly before heads of terms are signed, the buyer and their advisers need to settle on the acquisition structure. The two options carry materially different tax and risk profiles.
| Feature | Share purchase | Asset purchase |
|---|---|---|
| Stamp/SDLT cost on the deal | 0.5% stamp duty on the share consideration | SDLT on property at non-residential rates, up to 5% |
| Inherits company history | Yes, including historic liabilities and tax positions | No, buyer takes specific assets and assumes specific liabilities |
| NHS contract position | Contract remains in the company; change of ownership of the company still triggers notification obligations | Contract must be novated or re-applied for; specialist legal advice required |
| Goodwill CT relief | Restricted; CT relief on goodwill on a company purchase is only available in limited cases at fixed rates | Relief may be available through capital allowances on specific assets, not on the goodwill itself |
For the full structuring analysis, including worked tax examples, see Share vs asset purchase: pharmacy acquisition structuring. This checklist flags the decision; do not proceed to heads of terms without settling it.
Goodwill in the price and why it dominates
Goodwill in a community pharmacy acquisition is not the same as goodwill in a café or a solicitors' practice. It is driven almost entirely by the NHS contract and monthly item volume. A buyer paying a significant sum for a pharmacy is paying for a contracted, NHSBSA-reimbursed dispensing income stream that has barriers to entry written into statute.
Two tax points are load-bearing:
- Corporation tax relief on goodwill is restricted on a company purchase. Under HMRC's goodwill and relevant assets rules, relief is only available in limited cases at fixed rates when goodwill is acquired as part of a business purchased through a company. A buyer expecting to amortise goodwill against corporation tax profits in the normal way may be disappointed. Structuring decisions (asset vs share deal; individual vs company buyer) affect whether any relief is available at all.
- No specific multiple or benchmark is stated here. Pharmacy goodwill does trade on recognisable methods (adjusted EBITDA multiples and pence-per-item benchmarks), but the actual figure in any transaction depends on the specific pharmacy's item volume, contract type, location and trading history. Valuation stays at method level until a cited, sourced figure is in your hands from a specialist pharmacy broker.
For a deeper treatment, see Pharmacy goodwill: what it is and what drives its value.
Due diligence: the items a pharmacy buyer cannot skip
General business due diligence (audited accounts, lease, staff, litigation) applies, but a pharmacy has several layers that a generalist accountant will not know to pull.
FP34 and NHSBSA payment history
Prescriptions are submitted to the NHSBSA monthly on the FP34 schedule and payment arrives roughly two months later, with an advance on account (see the NHSBSA submission and payment process). Due diligence must include:
- At least 24 months of FP34 submissions and corresponding NHSBSA payment remittances, to verify item volumes and reconcile against the accounts.
- Analysis of item volume trends: is the contract growing, flat or declining, and why?
- The advance-on-account balance at the point of sale, which is a working-capital item on completion.
Drug Tariff and Category M margin story
Gross margin on NHS dispensing is not stable. The Drug Tariff sets reimbursement prices and Category M clawbacks adjust the margin retrospectively to reflect actual purchase prices in the market. Due diligence should establish:
- Whether the reported gross margin reflects actual post-clawback income or a pre-clawback figure that flatters the profit picture.
- Whether any Category M clawback liabilities were outstanding at the accounts date.
- The pharmacy's Drug Tariff category and whether any imminent Drug Tariff changes affect the forward margin profile.
VAT mix
A community pharmacy is a VAT-mixed business: NHS-dispensed prescription drugs are zero-rated, most OTC retail is standard-rated, and some private services may be exempt or standard-rated depending on the supply. This means:
- The pharmacy almost certainly reclaims more input VAT than a pure retailer, but only if the retail scheme and partial-exemption position are correctly set up.
- Due diligence should confirm the VAT retail scheme in use, verify that it is appropriate for the actual sales mix, and check for any VAT assessments or disputes in the last four years.
- The VAT position is a day-one accounting task for the incoming owner; inheriting a mis-applied retail scheme creates a retrospective liability risk.
Lease, premises and TUPE
- Lease: Confirm the lease term, rent review mechanism, break clauses and, critically, whether the landlord's consent is required for an assignment or share sale. A lease that cannot be assigned kills an asset deal.
- TUPE: Staff employed in the pharmacy transfer to the buyer under the Transfer of Undertakings (Protection of Employment) Regulations 2006. Review all employment contracts, salary levels, holiday accrual and any outstanding grievances or tribunal claims before agreeing consideration.
- Pharmacy First and service income: Confirm which NHS advanced and enhanced services the pharmacy provides (Pharmacy First and similar) and whether those service agreements transfer or must be re-applied for under new ownership. Service income is a growing revenue line and a gap in provision affects day-one income.
Funding and affordability: what finance-ready means
Lenders who specialise in pharmacy acquisition finance (typically healthcare-specialist banks and brokers) assess the deal differently from a standard commercial property lender. They look at the contract, the item volume trend and the net income after NHSBSA reimbursement, not just the balance sheet.
Finance-ready accounts for a pharmacy buyer typically require:
- Two to three years of the target pharmacy's accounts, preferably audited or reviewed by a pharmacy-specialist accountant who can present them in a format lenders recognise.
- A working-capital model that accounts for the FP34 payment lag (cash in roughly two months after dispensing) and any Category M clawback timing.
- A clear picture of the VAT position and any outstanding liabilities that affect the net asset value.
For a first-time buyer working through the affordability question, the pharmacy purchase affordability calculator provides a scenario-level estimate of the funding gap and debt-service coverage. It is a planning tool and produces an estimate only, not an offer-ready or filing-ready figure. Your specific transaction has dimensions the calculator cannot model; use it to frame the conversation with a lender and then speak to us.
For a deeper treatment of first-time buyer finance, see First-time pharmacy buyer: financing your acquisition.
The end-to-end checklist
The table below sets out the acquisition journey in stages. Each stage identifies the accountant's role and the risk of skipping it.
| Stage | What it covers | Accountant's role | Risk if skipped |
|---|---|---|---|
| 1. Identify the right target | Pharmacy listing, item volume, contract type, location, competitor map | Screen item volumes and income profile against affordability; flag income-concentration risk | Overpaying for declining volume or a contract under threat |
| 2. Settle the acquisition structure | Share vs asset; individual vs company buyer; goodwill treatment; SDLT vs stamp duty | Model the tax cost of each structure including goodwill CT relief restriction | Wrong structure locked in at heads of terms; expensive to unwind |
| 3. Heads of terms | Price, structure, exclusivity, conditions precedent including NHS approval | Confirm the price allocation between goodwill, fixtures and property; flag any deferred consideration timing | Price allocation agreed verbally then disputed at completion |
| 4. NHS and GPhC notifications | Change-of-ownership notification under the 2013 Regulations; GPhC registration update; superintendent pharmacist appointment (companies) | Model the working-capital cost of the approval timeline; ensure FP34 continuity is planned | Gap in NHS registration means gap in dispensing income after completion |
| 5. Financial due diligence | 24+ months FP34 history; Drug Tariff and Category M margin; VAT retail scheme and partial exemption; management accounts vs NHSBSA remittances | Reconcile NHSBSA remittances to accounts; verify VAT scheme; identify clawback timing | Paying for margin that is not real; inheriting VAT or clawback liabilities |
| 6. Legal due diligence | Lease and assignment rights; TUPE and employment; historic litigation; company history (share deal) | Review employment cost schedule for TUPE; confirm leasehold improvements are correctly capitalised | Lease cannot be assigned; hidden employment liabilities; historic company tax problems (share deal) |
| 7. Finance and funding | Lender presentations; working-capital model; VAT registration day one | Prepare finance-ready accounts and working-capital model for lenders; confirm day-one VAT position | Lender declines; working-capital shortage in month one due to FP34 lag |
| 8. Completion accounts | Locked-box or completion accounts mechanism; advance-on-account balance; stock and WIP | Prepare or review completion accounts; agree the advance-on-account treatment | Buyer and seller dispute the net asset value; delayed settlement |
| 9. Day-one accounting setup | Open books; VAT retail scheme election; FP34 submission calendar; payroll under new entity | Configure the VAT retail scheme for the actual sales mix; set FP34 submission calendar; transfer payroll | First months of trading produce mis-stated accounts; VAT overpaid from day one |
| 10. Post-completion monitoring | First NHSBSA remittance reconciliation; Drug Tariff movement; Pharmacy First service income tracking | Reconcile first remittance to item volumes; set up monthly margin variance analysis | Category M clawbacks and Drug Tariff changes not spotted until year-end; cash shortfall |
Getting deal support
A pharmacy acquisition has more moving parts than most business purchases: a regulated contract asset, a bespoke cash-flow cycle, a VAT-mixed structure and a structuring decision that determines the tax cost of the goodwill for years after completion. General business accountants handle the mechanics but routinely miss the pharmacy-specific layers.
The areas where specialist support makes the clearest difference are financial due diligence (reconciling NHSBSA remittances, the Category M margin story and the VAT retail scheme position), acquisition structuring (share vs asset, goodwill treatment, CT relief), and day-one accounting setup so that the first months of trading are not spent correcting inherited problems.
For a structured conversation about your acquisition, visit the buying a pharmacy hub or use the purchase affordability calculator to frame your numbers before a first call. If you are ready to discuss deal support, get in touch.